bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
bioAffinity Technologies closed a $4 million private placement offering priced at-the-market under Nasdaq rules. The offering consisted of pre-funded warrants to purchase approximately 8.46 million shares of common stock at a combined effective price of $0.4657, along with accompanying common warrants exercisable at $0.4727.
Key figures
- Deal Value Usd
- 4000000
- Offering Price
- 0.4657
- Shares Offered
- 8462027
- Warrant expiration years
- 5
- Common warrant exercise price
- 0.4727
- Pre funded warrant exercise price
- 0.007
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.